{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:27:39Z","timestamp":1793125659409,"version":"4.5.0"},"reference-count":206,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Eosinophils are leukocytes which reside in the gastrointestinal tract under homeostatic conditions, except for the esophagus which is normally devoid of eosinophils. Research on eosinophils has primarily focused on anti-helminth responses and type 2 immune disorders. In contrast, the search for a role of eosinophils in chronic intestinal inflammation and fibrosis has been limited. With a shift in research focus from adaptive to innate immunity and the fact that the eosinophilic granules are filled with inflammatory mediators, eosinophils are becoming a point of interest in inflammatory bowel diseases. In the current review we summarize eosinophil characteristics and recruitment as well as the current knowledge on presence, inflammatory and pro-fibrotic functions of eosinophils in inflammatory bowel disease and other chronic inflammatory conditions, and we identify research gaps which should be covered in the future.<\/jats:p>","DOI":"10.3389\/fimmu.2021.754413","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T17:56:00Z","timestamp":1634752560000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":71,"title":["Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?"],"prefix":"10.3389","volume":"12","author":[{"given":"Inge","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ceulemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Wauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Breynaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Vermeire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Verstockt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Vanuytsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: Current State of the Art","volume":"13","author":"De Souza","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30111-X","article-title":"Genetics of Inflammatory Bowel Disease: Beyond NOD2","volume":"2","author":"Mirkov","year":"2017","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00942","article-title":"Interactions Between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2014.00024","article-title":"Intestinal Epithelium in Inflammatory Bowel Disease","volume":"1","author":"Coskun","year":"2014","journal-title":"Front Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2009.31","article-title":"Intestinal Fibrosis in IBD - A Dynamic, Multifactorial Process","volume":"6","author":"Rieder","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.09.047","article-title":"Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases","volume":"152","author":"Rieder","year":"2017","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: From Mechanisms to Medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1172\/JCI93557","article-title":"Extracellular Matrix as a Driver of Progressive Fibrosis","volume":"128","author":"Herrera","year":"2018","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-020-0281-y","article-title":"The Emerging Roles of Eosinophils in Mucosal Homeostasis","volume":"13","author":"Shah","year":"2020","journal-title":"Mucosal Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053055","article-title":"Translating Immunology Into Therapeutic Concepts for Inflammatory Bowel Disease","volume":"36","author":"Uhlig","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz024","article-title":"Eosinophils in Inflammatory Bowel Disease","volume":"25","author":"Filippone","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20018","article-title":"Comparative Study of Eosinophil Chemotaxis, Adhesion, and Degranulation In Vitro in Ulcerative Colitis and Crohn\u2019s Disease","volume":"13","author":"Coppi","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.3.404","article-title":"A Reproducible Grading Scale for Histological Assessment of Inflammation in Ulcerative Colitis","volume":"47","author":"Geboes","year":"2000","journal-title":"Gut"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12639","article-title":"Eosinophilia \u2013 Associated Basal Plasmacytosis: An Early and Sensitive Histologic Feature of Inflammatory Bowel Disease","volume":"125","author":"Canavese","year":"2017","journal-title":"Apmis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/codi.12725","article-title":"Severe Eosinophilic Infiltration in Colonic Biopsies Predicts Patients With Ulcerative Colitis Not Responding to Medical Therapy","volume":"16","author":"Zezos","year":"2014","journal-title":"Color Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05687.x","article-title":"Elevated Serum Eotaxin Levels in Patients With Inflammatory Bowel Disease","volume":"97","author":"Mir","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/00365520120163","article-title":"Increased Serum Levels of Eotaxin in Patients With Inflammatory Bowel Disease","volume":"36","author":"Chen","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-015-0458-9","article-title":"Do We Know What Causes Eosinophilic Esophagitis? A Mechanistic Update","volume":"176","author":"Runge","year":"2015","journal-title":"Curr Gastroenterol Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00051","article-title":"Understanding Interleukin 33 and Its Roles in Eosinophil Development","volume":"4","author":"Johnston","year":"2017","journal-title":"Front Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri3341","article-title":"Eosinophils: Changing Perspectives in Health and Disease","volume":"13","author":"Rosenberg","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2001.790114.x","article-title":"Gastrointestinal Eosinophils","volume":"179","author":"Rothenberg","year":"2001","journal-title":"Immunol Rev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.5.2349","article-title":"Cloning, Expression, and Characterization of the Human Eosinophil Eotaxin Receptor","volume":"183","author":"Daugherty","year":"1996","journal-title":"J Exp Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.95","article-title":"Functions of Tissue-Resident Eosinophils","volume":"17","author":"Weller","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00093","article-title":"The Biology of Eosinophils and Their Role in Asthma","volume":"4","author":"McBrien","year":"2017","journal-title":"Front Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.072595","article-title":"The Role of Eosinophils in Inflammatory Bowel Disease","volume":"54","author":"Al-Haddad","year":"2005","journal-title":"Gut"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(06)00371-X","article-title":"Functional Expression of the Eotaxin Receptor CCR3 in T Lymphocytes Co-Localizing With Eosinophils","volume":"7","author":"Gerber","year":"1997","journal-title":"Curr Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2009.115","article-title":"Eosinophils and Th2 Immunity: Contemporary Insights","volume":"88","author":"Spencer","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxx045","article-title":"Antibody Therapy for the Management of Severe Asthma With Eosinophilic Inflammation","volume":"29","author":"Ohta","year":"2017","journal-title":"Int Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.21.3.f160","article-title":"Eotaxin: An Essential Mediator of Eosinophil Trafficking Into Mucosal Tissues","volume":"21","author":"Rothenberg","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.10.7390","article-title":"Intestinal Macrophage\/Epithelial Cell-Derived CCL11\/Eotaxin-1 Mediates Eosinophil Recruitment and Function in Pediatric Ulcerative Colitis","volume":"181","author":"Ahrens","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.13.7725","article-title":"Molecular Cloning of Human Eotaxin, an Eosinophil-Selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3","volume":"271","author":"Kitaura","year":"1996","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119624","article-title":"High Expression of the Chemokine Receptor CCR3 in Human Blood Basophils. Role in Activation by Eotaxin, MCP-4, and Other Chemokines","volume":"100","author":"Uguccioni","year":"1997","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65222-4","article-title":"Tryptase-Chymase Double-Positive Human Mast Cells Express the Eotaxin Receptor CCR3 and Are Attracted by CCR3-Binding Chemokines","volume":"155","author":"Romagnani","year":"1999","journal-title":"Am J Pathol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5334.2005","article-title":"Selective Expression of the Eotaxin Receptor CCR3 by Human T Helper 2 Cells","volume":"277","author":"Sallusto","year":"1997","journal-title":"Science (80)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.7.1920","article-title":"Eotaxin Is a Natural Antagonist for CCR2 and an Agonist for CCR5","volume":"97","author":"Ogilvie","year":"2001","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200323787","article-title":"CCR3 Functional Responses Are Regulated by Both CXCR3 and Its Ligands CXCL9, CXCL10 and CXCL11","volume":"33","author":"Xanthou","year":"2003","journal-title":"Eur J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.3.881","article-title":"Eotaxin: A Potent Eosinophil Chemoattractant Cytokine Detected in a Guinea Pig Model of Allergic Airways Inflammation","volume":"179","author":"Jose","year":"1994","journal-title":"J Exp Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.3.1211","article-title":"Constitutive and Allergen-Induced Expression of Eotaxin mRNA in the Guinea Pig Lung","volume":"181","author":"Rothenberg","year":"1995","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-4310(99)01635-4","article-title":"Eotaxin and Eosinophil Recruitment: Implications for Human Disease","volume":"6","author":"Rankin","year":"2000","journal-title":"Mol Med Today"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.2.555","article-title":"Detection of MCP-4 in Dermal Fibroblasts and Its Activation of the Respiratory Burst in Human Eosinophils","volume":"160","author":"Petering","year":"1998","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.12.2171","article-title":"Eotaxin-2, a Novel CC Chemokine That Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes","volume":"185","author":"Forssmann","year":"1997","journal-title":"J Exp Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2010.04248.x","article-title":"Increased Expression of Chemokine Receptor CCR3 and Its Ligands in Ulcerative Colitis: The Role of Colonic Epithelial Cells in In Vitro Studies","volume":"162","author":"Manousou","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(99)00699-1","article-title":"Fecal Eosinophil Granule-Derived Proteins Reflect Disease Activity in Inflammatory Bowel Disease","volume":"94","author":"Saitoh","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1159\/000049502","article-title":"Eotaxin-1-Deficient Mice Develop Airway Eosinophilia and Airway Hyperresponsiveness","volume":"126","author":"Tomkinson","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.4.785","article-title":"Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen- Induced Tissue Eosinophilia","volume":"185","author":"Rothenberg","year":"1997","journal-title":"J Exp Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.066423","article-title":"Eosinophil Granulocytes Are Activated During the Remission Phase of Ulcerative Colitis","volume":"54","author":"Amin","year":"2005","journal-title":"Gut"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(90)90485-D","article-title":"Localization of a Human T-Cell-Specific Gene, RANTES (D17S136E), to Chromosome 17q11.2-q12","volume":"553","author":"Donlon","year":"1990","journal-title":"Genomics"},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.163.11.6321","article-title":"Eosinophil Chemotactic Chemokines (Eotaxin, Eotaxin-2, RANTES, Monocyte Chemoattractant Protein-3 (MCP-3), and MCP-4), and C-C Chemokine Receptor 3 Expression in Bronchial Biopsies From Atopic and Nonatopic (Intrinsic) Asthmatics","volume":"163","author":"Ying","year":"1999","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.034983","article-title":"Comparison of RANTES Expression in Crohn\u2019s Disease and Ulcerative Colitis: An Aid in the Differential Diagnosis","volume":"59","author":"Ansari","year":"2006","journal-title":"J Clin Pathol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03063","article-title":"CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania Major Infection","volume":"9","author":"Ford","year":"2019","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64177-6","article-title":"Eosinophil Recruitment in Type-2 Hypersensitivity Pulmonary Granulomas: Source and Contribution of Monocyte Chemotactic Protein-3 (CCL7)","volume":"161","author":"Shang","year":"2002","journal-title":"Am J Pathol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10787-013-0177-5","article-title":"The Multiple Faces of CCL13 in Immunity and Inflammation","volume":"21","author":"Mendez-Enriquez","year":"2013","journal-title":"Inflammopharmacology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/157489111796887855","article-title":"Current Update on Eosinophilic Lung Diseases and Anti-IL-5 Treatment","volume":"6","author":"Samitas","year":"2011","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.6b00367","article-title":"Activation of Human Peripheral Blood Eosinophils by Cytokines in a Comparative Time-Course Proteomic\/Phosphoproteomic Study","volume":"16","author":"Soman","year":"2017","journal-title":"J Proteome Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1067\/mai.2000.110164","article-title":"Systemic Activation of Basophils and Eosinophils: Markers and Consequences","volume":"106","author":"Bochner","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0807513","article-title":"Different Regulation of Eosinophil Activity in Crohn\u2019s Disease Compared With Ulcerative Colitis","volume":"84","author":"Lampinen","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2017.03.040","article-title":"History of Interleukin-4","volume":"176","author":"Paul","year":"2015","journal-title":"Cytokine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/ni1558","article-title":"A Mechanism for the Initiation of Allergen-Induced T Helper Type 2 Responses","volume":"9","author":"Sokol","year":"2008","journal-title":"Nat Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.4.1091","article-title":"The Presence of Interleukin 4 During In Vitro Priming Determines the Lymphoklne-Producing Potential of CD4+ T Cells From T Cell Receptor Transgenic Mice","volume":"176","author":"Seder","year":"1992","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.13.6065","article-title":"Differential Regulation of T Helper Phenotype Development by Interleukins 4 and 10 in an Alpha Beta T-Cell-Receptor Transgenic System","volume":"89","author":"Hsieh","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1994.tb39809.x","article-title":"IL-4-Induced Migration of Eosinophils in Allergic Inflammation","volume":"725","author":"Dubois","year":"1994","journal-title":"Ann NY Acad Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.03.012","article-title":"The Role of Interleukin-13 in Chronic Inflammatory Intestinal Disorders","volume":"18","author":"Giuffrida","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.micinf.2005.09.006","article-title":"Induction of Chronic Colitis in IL-10 Deficient Mice Requires IL-4","volume":"8","author":"Specht","year":"2006","journal-title":"Microbes Infect"},{"key":"B64","doi-asserted-by":"publisher","first-page":"7117","DOI":"10.1038\/s41598-017-07738-z","article-title":"Transcriptome Profiling of Mouse Colonic Eosinophils Reveals a Key Role for Eosinophils in the Induction of s100a8 and s100a9 in Mucosal Healing","volume":"7","author":"Reichman","year":"2017","journal-title":"Sci Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.07.008","article-title":"Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis","volume":"43","author":"Griseri","year":"2015","journal-title":"Immunity"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200057","article-title":"Intestinal CCL11 and Eosinophilic Inflammation Is Regulated by Myeloid Cell\u2013Specific RelA\/p65 in Mice","volume":"190","author":"Waddell","year":"2013","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12319","article-title":"Therapeutic Activity of an Interleukin-4\/Interleukin-13 Dual Antagonist on Oxazolone-Induced Colitis in Mice","volume":"143","author":"Kasaian","year":"2014","journal-title":"Immunology"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0040214","article-title":"Oxazolone-Induced Colitis in BALB\/C Mice: A New Method to Evaluate the Efficacy of Therapeutic Agents for Ulcerative Colitis","volume":"96","author":"Kojima","year":"2004","journal-title":"J Pharmacol Sci"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scisignal.1.51.pe55","article-title":"Untangling the Complex Web of IL-4-and IL-13-Mediated Signaling Pathways","volume":"1","author":"Wills-Karp","year":"2008","journal-title":"Sci Signal"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00453-3","article-title":"Oxazolone Colitis, a Th2 Colitis Model Resembling Ulcerative Colitis, Is Mediated by IL-13-Producing NK-T Cells","volume":"17","author":"Heller","year":"2002","journal-title":"Immunity"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072484","article-title":"The Transcription Factor NFATc2 Controls IL-6-Dependent T Cell Activation in Experimental Colitis","volume":"205","author":"Weigmann","year":"2008","journal-title":"J Exp Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.10.1929","article-title":"Oxazolone Colitis: A Murine Model of T Helper Cell Type 2 Colitis Treatable With Antibodies to Interleukin 4","volume":"188","author":"Boirivant","year":"1998","journal-title":"J\u00a0Exp Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.gastro.2011.09.044","article-title":"B Cells That Produce Immunoglobulin E Mediate Colitis in BALB\/c Mice","volume":"142","author":"Hoving","year":"2012","journal-title":"Gastroenterology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.47.11.1015","article-title":"Decreased Mucosal Interleukin-4 (IL-4) Production in Gut Inflammation","volume":"47","author":"Karttunnen","year":"1994","journal-title":"J Clin Pathol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.6.1897","article-title":"Immunoreactivity for Interleukin 3 and 5 and Granulocyte\/Macrophage Colony-Stimulating Factor of Intestinal Mucosa in Bronchial Asthma","volume":"182","author":"Wallaert","year":"1995","journal-title":"J Exp Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-Helper Type 2-Driven Inflammation Defines Major Subphenotypes of Asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jaci.2015.05.037","article-title":"Increased Numbers of Activated Group 2 Innate Lymphoid Cells in the Airways of Patients With Severe Asthma and Persistent Airway Eosinophilia","volume":"137","author":"Smith","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1089\/107999004323065057","article-title":"The Role of Human Mast Cell-Derived Cytokines in Eosinophil Biology","volume":"24","author":"Shakoory","year":"2004","journal-title":"J Interf Cytokine Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.6.3452","article-title":"Invariant NKT Cells Biased for IL-5 Production Act as Crucial Regulators of Inflammation","volume":"179","author":"Sakuishi","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2008.02958.x","article-title":"Eosinophils: Biological Properties and Role in Health and Disease","volume":"38","author":"Hogan","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.86","article-title":"Innate Lymphoid Cells: Major Players in Inflammatory Diseases","volume":"17","author":"Ebbo","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1159\/000072140","article-title":"Association of Interleukin-5 and Eotaxin With Acute Exacerbation of Asthma","volume":"131","author":"Park","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3838","article-title":"Targeting Eosinophils in Allergy, Inflammation and Beyond","volume":"12","author":"Fulkerson","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01514","article-title":"Interleukin-5 in the Pathophysiology of Severe Asthma","volume":"10","author":"Pelaia","year":"2019","journal-title":"Front Physiol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010659803912","article-title":"IL-5 and TNF-\u03b1 Participate in Recruitment of Eosinophils to Intestinal Mucosa in Ulcerative Colitis","volume":"46","author":"Lampinen","year":"2001","journal-title":"Dig Dis Sci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.1016\/j.jaci.2004.01.053","article-title":"Beneficial Effects of Eosinophils in Colitis Induced by Dextran Sulfate Sodium","volume":"113","author":"Kobayashi","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa225","article-title":"Improvement in Ulcerative Colitis by Administration of Benralizumab for Comorbid Refractory Bronchial Asthma: A Novel Clinical Observation","volume":"27","author":"Sugimoto","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"B88","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/WOX.0b013e31821188e0","article-title":"Interleukin-13 Signaling and Its Role in Asthma","volume":"4","author":"Rael","year":"2011","journal-title":"World Allergy Organ J"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.3.1471-1479.2006","article-title":"Interleukin-5 (IL-5) Augments the Progression of Liver Fibrosis by Regulating IL-13 Activity","volume":"74","author":"Reiman","year":"2006","journal-title":"Infect Immun"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v97.9.2673","article-title":"The Interleukin-13 Receptor Alpha2 Chain: An Essential Component for Binding and Internalization But Not for Interleukin-13-Induced Signal Transduction Through the STAT6 Pathway","volume":"97","author":"Kawakami","year":"2001","journal-title":"Blood"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02983","article-title":"Effects of Epithelial IL-13r\u03b12 Expression in Inflammatory Bowel Disease","volume":"9","author":"Verstockt","year":"2018","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0189-6","article-title":"Anti-IL-13Ra2 Therapy Promotes Recovery in a Murine Model of Inflammatory Bowel Disease","volume":"12","author":"Karmele","year":"2019","journal-title":"Mucosal Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.2174\/156652409788970652","article-title":"The Signaling Function of the IL-13Ralpha2 Receptor in the Development of Gastrointestinal Fibrosis and Cancer Surveillance","volume":"9","author":"Strober","year":"2009","journal-title":"Curr Mol Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.178665","article-title":"Mucosal Gene Signatures to Predict Response to Infliximab in Patients With Ulcerative Colitis","volume":"58","author":"Arijs","year":"2009","journal-title":"Gut"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21301","article-title":"Predictive Value of Epithelial Gene Expression Profiles for Response to Infliximab in Crohn\u2019s Disease","volume":"16","author":"Arijs","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15126","article-title":"Mucosal IL13RA2 Expression Predicts Nonresponse to Anti-TNF Therapy in Crohn\u2019s Disease","volume":"49","author":"Verstockt","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"B97","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1136\/gutjnl-2014-308337","article-title":"Anrukinzumab, an Anti-Interleukin 13 Monoclonal Antibody, in Active UC: Efficacy and Safety From a Phase IIa Randomised Multicentre Study","volume":"64","author":"Reinisch","year":"2015","journal-title":"Gut"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00475","article-title":"The ST2\/IL-33 Axis in Immune Cells During Inflammatory Diseases","volume":"8","author":"Griesenauer","year":"2017","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/ACI.0000000000000497","article-title":"Innate Lymphoid Cells in Asthma: Pathophysiological Insights From Murine Models to Human Asthma Phenotypes","volume":"19","author":"Jonckheere","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3MA0517-175R","article-title":"Downregulated Eosinophil Activity in Ulcerative Colitis With Concomitant Primary Sclerosing Cholangitis","volume":"104","author":"Lampinen","year":"2018","journal-title":"J Leukoc Biol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an Interleukin-1-Like Cytokine That Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2015.11.028","article-title":"IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis","volume":"186","author":"De Salvo","year":"2016","journal-title":"Am J Pathol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.5.3143","article-title":"Regulation and Function of T1\/ST2 Expression on CD4+ T Cells: Induction of Type 2 Cytokine Production by T1\/ST2 Cross-Linking","volume":"166","author":"Meisel","year":"2001","journal-title":"J Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301785","article-title":"Neutralisation of the Interleukin-33\/ST2 Pathway Ameliorates Experimental Colitis Through Enhancement of Mucosal Healing in Mice","volume":"62","author":"Sedhom","year":"2013","journal-title":"Gut"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2011.01026","article-title":"Eosinophils: Multifaceted Biologic Propterties and Roles in Health and Disease","volume":"242","author":"Kita","year":"2011","journal-title":"Immunol Rev"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v87.9.3910.bloodjournal8793910","article-title":"Subcellular Localization of Transforming Growth Factor-\u03b1 in Human Eosinophil Granulocytes","volume":"87","author":"Egesten","year":"1996","journal-title":"Blood"},{"key":"B107","first-page":"173","article-title":"Eosinophil Cytokines in Allergy","volume-title":"Cytokine Effector Functions in Tissues","author":"Lacy","year":""},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-017-1350-1","article-title":"TGF-\u03b2 in Inflammatory Bowel Disease: A Key Regulator of Immune Cells, Epithelium, and the Intestinal Microbiota","volume":"52","author":"Ihara","year":"2017","journal-title":"J\u00a0Gastroenterol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1990.tb17931","article-title":"Transforming Growth Factor-Beta. Major Role in Regulation of Extracellular Matrix","volume":"580","author":"Roberts","year":"1990","journal-title":"Ann NY Acad Sci"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00484","article-title":"Eosinophils in Autoimmune Diseases","volume":"8","author":"Diny","year":"2017","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1007\/BF02355024","article-title":"Growth Factor mRNA Expression in Normal Colorectal Mucosa and in Uninvolved Mucosa From Ulcerative Colitis Patients","volume":"31","author":"Chowdhury","year":"1996","journal-title":"J Gastroenterol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8613031","article-title":"Expression of Transforming Growth Factors Alpha and Beta in Colonic Mucosa in Inflammatory Bowel Disease","volume":"110","author":"Babyatsky","year":"1996","journal-title":"Gastroenterology"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/359693a0","article-title":"Targeted Disruption of the Mouse Transforming Growth Factor-Beta 1 Gene Results in Multifocal Inflammatory Disease","volume":"359","author":"Shull","year":"1992","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079182","article-title":"Characterization of Dextran Sodium Sulfate-Induced Inflammation and Colonic Tumorigenesis in Smad3(-\/-) Mice With Dysregulated Tgf\u03b2","volume":"8","author":"Seamons","year":"2013","journal-title":"PloS One"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti- and Pro-Inflammatory Roles of TGF-\u03b2, IL-10, and IL-22 In Immunity and Autoimmunity","volume":"9","author":"Shomyseh","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(92)90237-M","article-title":"Localization of the Human Eosinophil Charcot-Leyden Crystal Protein (Lysophospholipase) Gene (CLC) to Chromosome 19 and the Human Ribonuclease 2 (Eosinophil-Derived Neurotoxin) and Ribonuclease 3 (Eosinophil Cationic Protein) Genes (RNS2 and RNS3) to Chromosome 14","volume":"13","author":"Mastrianni","year":"1991","journal-title":"Genomics"},{"key":"B117","article-title":"Chapter 12 - Eosinophils","volume-title":"Asthma and COPD","author":"Simon","year":"2008"},{"key":"B118","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-04404-2.10046-6","article-title":"Chapter 46 Eosinophil-Associated Gastrointestinal Disorders (EGID)","volume-title":"Clinical Immunology: Principles and Practice","author":"Zuo","year":"2008"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2013.34415","article-title":"Clinical Value of Serum Eosinophilic Cationic Protein Assessment in Children With Infflammatory Bowel Disease","volume":"10","author":"W\u0119drychowicz","year":"2014","journal-title":"Arch Med Sci"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3390\/jcm8122025","article-title":"Fecal Eosinophil Cationic Protein Is a Diagnostic and Predictive Biomarker in Young Adults With Inflammatory Bowel Disease","volume":"8","author":"Abedin","year":"2019","journal-title":"J Clin Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2005.10.008","article-title":"Role of Eosinophil Peroxidase in Host Defense and Disease Pathology","volume":"445","author":"Wang","year":"2006","journal-title":"Arch Biochem Biophys"},{"key":"B122","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-7234-3691-1.00044-1","article-title":"Chapter 24: Eosinophils and Eosinophilia","volume-title":"Clinical Immunology","author":"Kovalszki","year":"2013"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01223","article-title":"Increased Intraluminal Release of Eosinophil Granule Proteins EPO, ECP, EPX, and Cytokines in Ulcerative Colitis and Proctitis in Segmental Perfusion","volume":"94","author":"Carlson","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"120\u2014125","DOI":"10.1097\/00004836-200302000-00006","article-title":"Immunohistochemical Study of Intestinal Eosinophils in Inflammatory Bowel Disease","volume":"36","author":"Carvalho","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3182128512","article-title":"Role of Eosinophils in Inflammatory Bowel and Gastrointestinal Diseases","volume":"52","author":"Woodruff","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.4065\/72.2.117","article-title":"Increased Eosinophil Granule Proteins in Gut Lavage Fluid From Patients With Inflammatory Bowel Disease","volume":"72","author":"Levy","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.36.25933","article-title":"Eosinophil Peroxidase Nitrates Protein Tyrosyl Residues. Implications for Oxidative Damage by Nitrating Intermediates in Eosinophilic Inflammatory Disorders","volume":"274","author":"Wu","year":"1999","journal-title":"J Biol Chem"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1046\/j.1365-2036.2002.01378","article-title":"Oxidative Stress as a Pathogenic Factor in Inflammatory Bowel Disease -Radicals or Ridiculous","volume":"16","author":"Kruidenier","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00291.2018","article-title":"Peroxidasin and Eosinophil Peroxidase, But Not Myeloperoxidase, Contribute to Renal Fibrosis in the Murine Unilateral Ureteral Obstruction Model","volume":"316","author":"Colon","year":"2019","journal-title":"Am J Physiol Ren Physiol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.9.5664","article-title":"Immunopathogenesis of Experimental Ulcerative Colitis Is Mediated by Eosinophil Peroxidase","volume":"172","author":"Forbes","year":"2004","journal-title":"J Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2019.1670251","article-title":"Prognostic Significance of Faecal Eosinophil Granule Proteins in Inflammatory Bowel Disease","volume":"54","author":"Amcoff","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001542","article-title":"Fecal Calprotectin and Eosinophil-Derived Neurotoxin in Healthy Children Between 0 and 12 Years","volume":"65","author":"Roca","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.10.7340","article-title":"Major Basic Protein Homolog (MBP2): A Specific Human Eosinophil Marker","volume":"177","author":"Plager","year":"2006","journal-title":"J Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00005.2003","article-title":"An In Vitro Airway Wall Model of Remodeling","volume":"285","author":"Choe","year":"2003","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00015.2005","article-title":"Eosinophils Alter Colonic Epithelial Barrier Function: Role for Major Basic Protein","volume":"289","author":"Furuta","year":"2005","journal-title":"Am J Physiol - Gastrointest Liver Physiol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0185(199811)252:3<418::AID-AR10>3.0.CO;2-1","article-title":"Eosinophil Infiltration and Degranulation in Normal Human Tissue","volume":"252","author":"Kato","year":"1998","journal-title":"Anat Rec"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.402","article-title":"Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype","volume":"112","author":"Click","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2329-7","article-title":"Recurrent Blood Eosinophilia in Ulcerative Colitis Is Associated With Severe Disease and Primary Sclerosing Cholangitis","volume":"58","author":"Barrie","year":"2013","journal-title":"Dig Dis Sci"},{"key":"B139","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4049\/jimmunol.1400413","article-title":"Roles and Regulation of Gastrointestinal Eosinophils in Immunity and Disease","volume":"193","author":"Jung","year":"2014","journal-title":"J Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300150","article-title":"Eosinophils and Primary Biliary Cirrhosis - Stoking the Fire","volume":"30","author":"Neuberger","year":"1999","journal-title":"Hepatology"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/10.10.1421","article-title":"IL-4 and IL-13 Specifically Increase Adhesion Molecule and Inflammatory Cytokine Expression in Human Lung Fibroblasts","volume":"10","author":"Doucet","year":"1998","journal-title":"Int Immunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.4.2083","article-title":"Dual Roles of IL-4 in Lung Injury and Fibrosis","volume":"170","author":"Huaux","year":"2003","journal-title":"J Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/s1885-5857(08)60014-6","article-title":"Interleukin-4 and Cardiac Fibrosis in Patients With Heart Failure","volume":"60","author":"Rosell\u00f3-Llet\u00ed","year":"2007","journal-title":"Rev Espa\u00f1ola Cardiol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2619::AID-IMMU2619>3.0.CO;2-M","article-title":"Anti-IL-4 Treatment Prevents Dermal Collagen Deposition in the Tight-Skin Mouse Model of Scleroderma","volume":"28","author":"Ong","year":"1998","journal-title":"Eur J Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781107415324.004","article-title":"Anti-IL-4 Treatment of Schistosoma Mansoni-Infected Mice Inhibits Development of T Cells and non-B, Non-T Cells Expressing Th2 Cytokines While Decreasing Egg-Induced Hepatic Fibrosis","volume":"53","author":"Cheever","year":"1994","journal-title":"J Immunol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path","article-title":"Cellular and Molecular Mechanisms of Fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of Fibrosis: Therapeutic Translation for Fibrotic Disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095937","article-title":"The Immunology of Fibrosis","volume":"31","author":"Wick","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i28.3635","article-title":"Cellular and Molecular Mechanisms of Intestinal Fibrosis","volume":"18","author":"Speca","year":"2012","journal-title":"World J Gastroenterol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1126\/scitranslmed.aan0333","article-title":"Eosinophil Depletion Suppresses Radiation-Induced Small Intestinal Fibrosis","volume":"10","author":"Takemura","year":"2018","journal-title":"Sci Transl Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.6.4020","article-title":"IL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-Beta Independent","volume":"173","author":"Kaviratne","year":"2004","journal-title":"J Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.6.809","article-title":"Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor \u03b21","volume":"194","author":"Lee","year":"2001","journal-title":"J Exp Med"},{"key":"B153","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1111\/ajt.14027","article-title":"Select Effects of IL-13 in Driving Tissue Repair and Fibrosis","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2019.11.5.604","article-title":"Genes and Pathways Regulating Decline in Lung Function and Airway Remodeling in Asthma","volume":"11","author":"Hur","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"B155","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pupt.2017.05.007","article-title":"IL-13 and Idiopathic Pulmonary Fibrosis: Possible Links and New Therapeutic Strategies","volume":"45","author":"Passalacqua","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"key":"B156","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1038\/s41467-018-07359-8","article-title":"Therapeutic Faecal Microbiota Transplantation Controls Intestinal Inflammation Through IL10 Secretion by Immune Cells","volume":"9","author":"Burrello","year":"2018","journal-title":"Nat Commun"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301072","article-title":"IL-13 Orchestrates Resolution of Chronic Intestinal Inflammation via Phosphorylation of Glycogen Synthase Kinase-3\u03b2","volume":"192","author":"Fichtner-Feigl","year":"2014","journal-title":"J Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000512","article-title":"Eosinophils and IL-33 Perpetuate Chronic Inflammation and Fibrosis in a Pediatric Population With Stricturing Crohn\u2019s Ileitis","volume":"21","author":"Masterson","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms19092532","article-title":"Targeting TGF-\u03b2 Signaling in Kidney Fibrosis","volume":"19","author":"Isaka","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2016-0307TR","article-title":"Transforming Growth Factor \u03b21 Function in Airway Remodeling and Hyperresponsiveness: The Missing Link","volume":"56","author":"Ojiaku","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40139-015-0089-8","article-title":"TGF-\u03b2 in Hepatic Stellate Cell Activation and Liver Fibrogenesis: Updated","volume":"3","author":"Dewidar","year":"2019","journal-title":"Curr Pathobiol Rep"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00048.2001","article-title":"Differential Expression of TGF-Beta Isoforms by Normal and Inflammatory Bowel Disease Intestinal Myofibroblasts","volume":"282","author":"McKaig","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00000658-199901000-00009","article-title":"Transforming Growth Factor-Betas and Their Signaling Receptors Are Coexpressed in Crohn\u2019s Disease","volume":"229","author":"di Mola","year":"1999","journal-title":"Ann Surg"},{"key":"B164","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1465-9921-12-10","article-title":"Analysing the Eosinophil Cationic Protein - A Clue to the Function of the Eosinophil Granulocyte","volume":"12","author":"Bystrom","year":"2011","journal-title":"Respir Res"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-007-9032-4","article-title":"Eosinophil Cationic Protein Stimulates TGF-\u03b21 Release by Human Lung Fibroblasts in vitro","volume":"30","author":"Zagai","year":"2007","journal-title":"Inflammation"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.7.4861","article-title":"Eosinophil-Derived Cationic Proteins Activate the Synthesis of Remodeling Factors by Airway Epithelial Cells","volume":"177","author":"P\u00e9gorier","year":"2006","journal-title":"J Immunol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00311","article-title":"Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing","volume":"7","author":"Porto","year":"2016","journal-title":"Front Immunol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/path.4359","article-title":"Neutrophil Extracellular Traps Promote Differentiation and Function of Fibroblasts","volume":"233","author":"Chrysanthopoulou","year":"2014","journal-title":"J Pathol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0136-8","article-title":"Biological Function of Eosinophil Extracellular Traps in Patients With Severe Eosinophilic Asthma","volume":"50","author":"Choi","year":"2018","journal-title":"Exp Mol Med"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.04.003","article-title":"Gut Reactions: Eosinophils Add Another String to Their Bow","volume":"40","author":"Sutherland","year":"2014","journal-title":"Immunity"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0013-8","article-title":"Schistosomiasis","volume":"4","author":"McManus","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"B172","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00281-021-00856-x","article-title":"Intestinal Eosinophils, Homeostasis and Response to Bacterial Intrusion","volume":"43","author":"Gurtner","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1172\/JCI110024","article-title":"Effects of Corticosteroids on Eosinophil Chemotaxis and Adherence","volume":"67","author":"Altman","year":"1981","journal-title":"J Clin Invest"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.g3009","article-title":"Comparative Effectiveness of Long Term Drug Treatment Strategies to Prevent Asthma Exacerbations: Network Meta-Analysis","volume":"348","author":"Loymans","year":"2014","journal-title":"BMJ"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(88)90006-8","article-title":"Modulation of Collagen Metabolism by Glucocorticoids","volume":"37","author":"Oikarinen","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2007.07.013","article-title":"Retroperitoneal Fibrosis: Evolving Concepts","volume":"33","author":"Vaglio","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015101110","article-title":"Idiopathic Retroperitoneal Fibrosis","volume":"27","author":"Vaglio","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken405","article-title":"Pathogenesis and Therapeutic Approaches for Improved Topical Treatment in Localized Scleroderma and Systemic Sclerosis","volume":"48","author":"Badea","year":"2009","journal-title":"Rheumatology"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.03.018","article-title":"Assessment of Current Practice in the Diagnosis and Therapy of Idiopathic Pulmonary Fibrosis","volume":"102","author":"Peikert","year":"2008","journal-title":"Respir Med"},{"key":"B180","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/1753465808089363","article-title":"New Perspectives in the Treatment of Idiopathic Pulmonary Fibrosis","volume":"2","author":"Rogliani","year":"2008","journal-title":"Ther Adv Respir Dis"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2015.05.007","article-title":"Novel Therapies for Eosinophilic Disorders","volume":"35","author":"Bochner","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01927","article-title":"Infliximab Downregulates Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in Crohn\u2019s Disease Patients","volume":"19","author":"Di Sabatino","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.04.069","article-title":"Functional Modulation of Crohn\u2019s Disease Myofibroblasts by Anti-Tumor Necrosis Factor Antibodies","volume":"133","author":"Di Sabatino","year":"2007","journal-title":"Gastroenterology"},{"key":"B184","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/gutjnl-2016-312581","article-title":"Efficacy of Adalimumab in Patients With Crohn\u2019s Disease and Symptomatic Small Bowel Stricture: A Multicentre, Prospective, Observational Cohort (CREOLE) Study","volume":"67","author":"Bouhnik","year":"2018","journal-title":"Gut"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.07.004","article-title":"Drug-Induced Hypersensitivity Syndrome With Myocardial Involvement Treated With Tofacitinib","volume":"5","author":"Damsky","year":"2019","journal-title":"JAAD Case Rep"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2017.03.040","article-title":"Treatment of Hypereosinophilic Syndrome With Cutaneous Involvement With the JAK Inhibitors Tofacitinib and Ruxolitinib","volume":"176","author":"King","year":"2017","journal-title":"Physiol Behav"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-232558","article-title":"Treatment-Resistant Eosinophilic Oesophagitis Successfully Managed With Tofacitinib","volume":"12","author":"Mendoza Alvarez","year":"2019","journal-title":"BMJ Case Rep"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/JTS.1000355","article-title":"Tofacitinib Suppressed Remodeling of Pulmonary Eosinophilic Vasculitis in a Murine Model","volume":"6","author":"Matsumoto","year":"2019","journal-title":"J Transl Sci"},{"key":"B189","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Medical Treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx009","article-title":"Third European Evidence-Based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management","volume":"11","author":"Harbord","year":"2017","journal-title":"J Crohn\u2019s Colitis"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4110\/in.2020.20.e24","article-title":"The Emerging Role of Eosinophils as Multifunctional Leukocytes in Health and Disease","volume":"20","author":"Kim","year":"2020","journal-title":"Immune Netw"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz251","article-title":"Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases","volume":"26","author":"Kim","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2011.43.4.018","article-title":"Protective Effects of Basic Fibroblast Growth Factor in the Development of Emphysema Induced by Interferon-\u03b3","volume":"43","author":"Lee","year":"2011","journal-title":"Exp Mol Med"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1183\/1393003","article-title":"VEGF Induces ECM Synthesis and Fibroblast Activity in Human Lung Fibroblasts","volume":"50","author":"Larsson-Callerfelt","year":"2017","journal-title":"Eur Respir J"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312735","article-title":"Tofacitinib for Induction and Maintenance Therapy of Crohn\u2019s Disease: Results of Two Phase IIb Randomised Placebo-Controlled Trials","volume":"66","author":"Pan\u00e9s","year":"2017","journal-title":"Gut"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32537-5","article-title":"Clinical Remission in Patients With Moderate-to-Severe Crohn\u2019s Disease Treated With Filgotinib (the FITZROY Study): Results From a Phase 2, Double-Blind, Randomised, Placebo-Controlled Trial","volume":"389","author":"Vermeire","year":"2017","journal-title":"Lancet"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz203.663","article-title":"Effects of the Janus Kinase 1 (JAK1)-Selective Inhibitor Filgotinib on Circulating Cytokines and Whole-Blood Genes\/Pathways of Patients With Moderately to Severely Active Crohn\u2019s Disease (CD)","volume":"14","author":"Roblin","year":"2018","journal-title":"J Crohn\u2019s Colitis"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01747","article-title":"Treatment With Anti-CC Chemokine Receptor 3 Monoclonal Antibody or Dexamethasone Inhibits the Migration and Differentiation of Bone Marrow CD34+ Progenitor Cells in an Allergic Mouse Model","volume":"63","author":"Ben","year":"2008","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.07.039","article-title":"CCR3 Blockade Attenuates Eosinophilic Ileitis and Associated Remodeling","volume":"179","author":"Masterson","year":"2011","journal-title":"Am J Pathol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4047","article-title":"The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications","volume":"61","author":"Adar","year":"2016","journal-title":"Dig Dis Sci"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.090093","article-title":"Treatment With a Novel Chemokine-Binding Protein or Eosinophil Lineage-Ablation Protects Mice From Experimental Colitis","volume":"175","author":"Vieira","year":"2009","journal-title":"Am J Pathol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119045","article-title":"Eosinophil Recruitment to the Lung in a Murine Model of Allergic Inflammation: The Role of T Cells, Chemokines, and Adhesion Receptors","volume":"98","author":"Gonzalo","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"B203","first-page":"1213\u20141218","article-title":"Bertilimumab Cambridge Antibody Technology Group","volume":"5","author":"Ding","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.110734","article-title":"A Potent Human Anti-Eotaxin1 Antibody, CAT-213: Isolation by Phage Display and In Vitro and In Vivo Efficacy","volume":"319","author":"Main","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1177\/2050640613502900","article-title":"And EG. Inhibition of Eotaxin-1 (CCL-11) Ameliorates DSS-Induced Colitis - A Novel Potential Therapeutic Approach for Inflammatory Bowel Disease","volume":"1","author":"Adar","year":"2013","journal-title":"United Eur Gastroenterol J"},{"key":"B206","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1939-4551-7-32","article-title":"Anti-IL5 Therapy for Asthma and Beyond","volume":"7","author":"Mukherjee","year":"2014","journal-title":"World Allergy Organ J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.754413\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T20:31:02Z","timestamp":1673555462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.754413\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":206,"alternative-id":["10.3389\/fimmu.2021.754413"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.754413","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"article-number":"754413"}}